Investor · Berkeley Heights, NJ

David F. Natan

Open David in the network graph →

Filings

23

SEC Form D

Connections

105

co-filers

Capital

$1.0M

across filings

Active

Mar 2023

to Nov 2025

Most-connected co-filers (105)

Robert M. Konski · Tulsa, OK11 shared John P. Szafranski · Tulsa, OK8 shared Avraham F. Ben-Tzvi · Berkeley Heights, NJ8 shared Excolere Equity Partners Fund I Gp, Llc · Los Angeles, CA6 shared Excolere Equity Partners, Llc · Los Angeles, CA6 shared Jeff Gibson · Norfolk, VA5 shared Anthony W. Miller · Los Angeles, CA4 shared Peter C. Davis · Los Angeles, CA4 shared Jason B. Williams · FRANKLINTON, NC4 shared Marcelus C. Decoulode · Los Angeles, CA4 shared Richard St-Julien · New York, NY4 shared Excolere Equity Partners, Llc · Los Angeles, CA4 shared Kebir Ratnani · New York, NY4 shared Excolere Equity Partners Fund I Gp, Llc · Los Angeles, CA4 shared David Vanderhorst · New York, NY4 shared Excolere Equity Partners Fund I Gp, Llc · Los Angeles, CA4 shared Adrian Auman · New York, NY4 shared Justin R. Geller · DALLAS, TX3 shared Wallace M. Mehran · NEW YORK, NY3 shared Hardik Desai · Cleveland, OH3 shared Shivaji · Erlangen, 2M3 shared Julie Jacano · Cleveland, OH3 shared Investment Manager and Managing Member of the General Partner TA Realty LLC · Boston, MA3 shared Steven L. Decillis Ii · NEW YORK, NY3 shared

Recent filings (23)

Excolere Equity Partners Fund I, LPMar 2026 · 4 co-filers$400.0M Excolere Equity Partners Parallel Fund I, LPMar 2026 · 4 co-filers$400.0M TLB TopCo Holdings I, LLCNov 2025 · 45 co-filers TLB Holdings I, LLCMay 2025 · 43 co-filers Cyclacel Pharmaceuticals, Inc.Mar 2025 · 11 co-filers$1.0M Cyclacel Pharmaceuticals, Inc.Mar 2025 · 11 co-filers$1.0M Excolere Equity Partners Fund I, LPMar 2025 · 13 co-filers$400.0M Excolere Equity Partners Parallel Fund I, LPMar 2025 · 13 co-filers$400.0M Cyclacel Pharmaceuticals, Inc.Feb 2025 · 11 co-filers$25.0M Cyclacel Pharmaceuticals, Inc.Feb 2025 · 11 co-filers Cyclacel Pharmaceuticals, Inc.Feb 2025 · 11 co-filers Cyclacel Pharmaceuticals, Inc.Feb 2025 · 11 co-filers$25.0M Excolere Equity Partners Parallel Fund I, LPJan 2025 · 13 co-filers$400.0M Excolere Equity Partners Fund I, LPJul 2024 · 13 co-filers$400.0M Alpine Management Aggregator, LPSep 2023 · 28 co-filers Sunshine Biopharma, IncMay 2023 · 11 co-filers$5.0M Sunshine Biopharma, IncMay 2023 · 11 co-filers$5.0M TLB Holdings I, LLCMar 2023 · 22 co-filers$329.9M Alpine Management Aggregator, LPMar 2023 · 28 co-filers Sunshine Biopharma, IncApr 2022 · 11 co-filers$19.5M Sunshine Biopharma, IncApr 2022 · 11 co-filers$19.5M Sunshine Biopharma, IncMar 2022 · 11 co-filers$8.0M Sunshine Biopharma, IncMar 2022 · 11 co-filers$8.0M ForceField Energy Inc.Feb 2015 · 11 co-filers$1.8M ForceField Energy Inc.Feb 2015 · 11 co-filers$1.8M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See David in the interactive graph →